Service Robot Directory + US Certification Partner

A new market research report estimates the global service robotics sector is worth approximately $31.1 billion in 2026 and is forecast to expand at a compound annual growth rate of nearly 20% through 2034, reaching $131.9 billion. Growth is being driven by labor shortages, falling hardware costs, and the rapid integration of AI into mobile robot platforms. The figures reinforce the strong commercial opportunity for businesses investing in or renting service robots today.

A detailed analysis published on May 21, 2026 reveals that China now controls close to 80 percent of the global humanoid robot market, driven largely by domestic giants Unitree and AgiBot. The country has deployed autonomous humanoid robots at scale across factories and logistics centers, widening its lead over U.S. and European competitors. Analysts warn the gap is structural, not cyclical, and may be difficult for Western firms to close in the near term.

Elon Musk announced Tesla's Optimus humanoid robot is moving toward production with plans for broader deployment next year, starting with factory tasks before consumer use.

Autonomous mobile robot developer Seegrid announced its fleet has surpassed 20 million autonomous miles driven across customer production environments.

Mind Robotics, spun out of Rivian, raised $500M Series A in March 2026 at $2B valuation. Total funding reached $615M since late 2025 with focus on dexterous industrial robots.

Serve Robotics acquired Diligent Robotics, expanding its autonomous robotics platform from delivery service to hospital settings.

Medtronic received FDA clearance for its Hugo robotic system in urologic procedures. Johnson & Johnson plans FDA submission for its Ottava robot in early 2026.

CMR Surgical's Versius Plus received FDA 510(k) clearance for cholecystectomy procedures. The company announced that over 45,000 patients worldwide have been treated using the Versius Surgical Robotic System.

Medtronic received FDA clearance for its Stealth AXiS robotic system for spine surgery in February 2026, designed for hospitals and ambulatory surgery centers.

Stereotaxis won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter, a robotically navigated magnetic ablation catheter for cardiac ablation procedures treating heart arrhythmia.

CMR Surgical's Versius Plus received FDA 510(k) clearance for cholecystectomy procedures and is on track for commercialization in 2026. The company is advancing additional indications in the U.S.

Restore Robotics received additional FDA 510(k) clearances for remanufactured da Vinci Xi robotic surgical instruments in March 2026, expanding its portfolio of cleared instruments.